Global Weight Loss Drugs Market

Weight Loss Drugs Comprehensive Study by Type (Liquid, Tablets), Application (Weight-reducing Aid, Other) Players and Region - Global Market Outlook to 2026

Weight Loss Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Global Weight Loss Drug consumption is expected to grow in the forecasted period owing to a rise in awareness among people about their health and wellbeing. Weight loss drugs refer to a pharmacological agent used to reduce or control weight. The prominent drivers include consumer’s increased weight and increase in disposable income. According to the report in 2018 around 30% of People in the world are Obese or Overweight.This growth is primarily driven by Rising Number of Diseases Due to Over Weight and Increasing Prevalence of Lifestyle Diseases.

Globally, a noticeable market trend is evident Rapidly Growing Child Obesity. Major Players, such as Abbott Laboratories (United States), Amylin Pharmaceuticals, Inc. (United States), AstraZeneca Plc (United Kingdom), F.Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline Plc (United Kingdom), VIVUS, Inc. (United States), Lunan Pharmaceutical Group Corporation (China), Teva (Iseral) and Novartis (Switzerland) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

On 18th June 2018, Jenny Craig, the global leader in the weight loss industry, has launched DNA testing into its complete weight loss strategies.

Regulatory Insights:
FDA approves weight loss drugs which suppress appetite by affecting one or more neurotransmitters in the brain which also control appetite and mood. Various appetite suppressants increase the secretion of dopamine, norepinepheine or serotonin or inhbit the reuptake of these neurotransmitters into the nerve cell.

Market Drivers
  • Rising Number of Diseases Due to Over Weight
  • Increasing Prevalence of Lifestyle Diseases

Market Trend
  • Rapidly Growing Child Obesity

Restraints
  • Rising Incidence of Side Effects
  • Stringent Government Rules and Regulation


Challenges
Increasing Safety and Efficiency Requirement for Novel Drug

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Weight Loss Drugs Study Sheds Light on
— The Weight Loss Drugs Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Weight Loss Drugs industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Weight Loss Drugs industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Liquid
  • Tablets
By Application
  • Weight-reducing Aid
  • Other
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number of Diseases Due to Over Weight
      • 3.2.2. Increasing Prevalence of Lifestyle Diseases
    • 3.3. Market Challenges
      • 3.3.1. Increasing Safety and Efficiency Requirement for Novel Drug
    • 3.4. Market Trends
      • 3.4.1. Rapidly Growing Child Obesity
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Weight Loss Drugs, by Type, Application and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Weight Loss Drugs (Value)
      • 5.2.1. Global Weight Loss Drugs by: Type (Value)
        • 5.2.1.1. Liquid
        • 5.2.1.2. Tablets
      • 5.2.2. Global Weight Loss Drugs by: Application (Value)
        • 5.2.2.1. Weight-reducing Aid
        • 5.2.2.2. Other
      • 5.2.3. Global Weight Loss Drugs Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Weight Loss Drugs (Volume)
      • 5.3.1. Global Weight Loss Drugs by: Type (Volume)
        • 5.3.1.1. Liquid
        • 5.3.1.2. Tablets
      • 5.3.2. Global Weight Loss Drugs by: Application (Volume)
        • 5.3.2.1. Weight-reducing Aid
        • 5.3.2.2. Other
      • 5.3.3. Global Weight Loss Drugs Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Weight Loss Drugs (Price)
      • 5.4.1. Global Weight Loss Drugs by: Type (Price)
  • 6. Weight Loss Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Amylin Pharmaceuticals, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AstraZeneca Plc (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. F.Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GlaxoSmithKline Plc (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. VIVUS, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lunan Pharmaceutical Group Corporation (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Teva (Iseral)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novartis (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Weight Loss Drugs Sale, by Type, Application and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Weight Loss Drugs (Value)
      • 7.2.1. Global Weight Loss Drugs by: Type (Value)
        • 7.2.1.1. Liquid
        • 7.2.1.2. Tablets
      • 7.2.2. Global Weight Loss Drugs by: Application (Value)
        • 7.2.2.1. Weight-reducing Aid
        • 7.2.2.2. Other
      • 7.2.3. Global Weight Loss Drugs Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Weight Loss Drugs (Volume)
      • 7.3.1. Global Weight Loss Drugs by: Type (Volume)
        • 7.3.1.1. Liquid
        • 7.3.1.2. Tablets
      • 7.3.2. Global Weight Loss Drugs by: Application (Volume)
        • 7.3.2.1. Weight-reducing Aid
        • 7.3.2.2. Other
      • 7.3.3. Global Weight Loss Drugs Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Weight Loss Drugs (Price)
      • 7.4.1. Global Weight Loss Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Weight Loss Drugs: by Type(USD Million)
  • Table 2. Weight Loss Drugs Liquid , by Region USD Million (2015-2020)
  • Table 3. Weight Loss Drugs Tablets , by Region USD Million (2015-2020)
  • Table 4. Weight Loss Drugs: by Application(USD Million)
  • Table 5. Weight Loss Drugs Weight-reducing Aid , by Region USD Million (2015-2020)
  • Table 6. Weight Loss Drugs Other , by Region USD Million (2015-2020)
  • Table 7. South America Weight Loss Drugs, by Country USD Million (2015-2020)
  • Table 8. South America Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 9. South America Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 10. Brazil Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 11. Brazil Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 12. Argentina Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 13. Argentina Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 14. Rest of South America Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 15. Rest of South America Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 16. Asia Pacific Weight Loss Drugs, by Country USD Million (2015-2020)
  • Table 17. Asia Pacific Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 18. Asia Pacific Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 19. China Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 20. China Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 21. Japan Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 22. Japan Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 23. India Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 24. India Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 25. South Korea Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 26. South Korea Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 27. Taiwan Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 28. Taiwan Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 29. Australia Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 30. Australia Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 31. Rest of Asia-Pacific Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 32. Rest of Asia-Pacific Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 33. Europe Weight Loss Drugs, by Country USD Million (2015-2020)
  • Table 34. Europe Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 35. Europe Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 36. Germany Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 37. Germany Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 38. France Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 39. France Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 40. Italy Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 41. Italy Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 42. United Kingdom Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 43. United Kingdom Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 44. Netherlands Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 45. Netherlands Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 46. Rest of Europe Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 47. Rest of Europe Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 48. MEA Weight Loss Drugs, by Country USD Million (2015-2020)
  • Table 49. MEA Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 50. MEA Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 51. Middle East Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 52. Middle East Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 53. Africa Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 54. Africa Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 55. North America Weight Loss Drugs, by Country USD Million (2015-2020)
  • Table 56. North America Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 57. North America Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 58. United States Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 59. United States Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 60. Canada Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 61. Canada Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 62. Mexico Weight Loss Drugs, by Type USD Million (2015-2020)
  • Table 63. Mexico Weight Loss Drugs, by Application USD Million (2015-2020)
  • Table 64. Weight Loss Drugs Sales: by Type(Units)
  • Table 65. Weight Loss Drugs Sales Liquid , by Region Units (2015-2020)
  • Table 66. Weight Loss Drugs Sales Tablets , by Region Units (2015-2020)
  • Table 67. Weight Loss Drugs Sales: by Application(Units)
  • Table 68. Weight Loss Drugs Sales Weight-reducing Aid , by Region Units (2015-2020)
  • Table 69. Weight Loss Drugs Sales Other , by Region Units (2015-2020)
  • Table 70. South America Weight Loss Drugs Sales, by Country Units (2015-2020)
  • Table 71. South America Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 72. South America Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 73. Brazil Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 74. Brazil Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 75. Argentina Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 76. Argentina Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 77. Rest of South America Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 78. Rest of South America Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 79. Asia Pacific Weight Loss Drugs Sales, by Country Units (2015-2020)
  • Table 80. Asia Pacific Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 81. Asia Pacific Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 82. China Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 83. China Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 84. Japan Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 85. Japan Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 86. India Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 87. India Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 88. South Korea Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 89. South Korea Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 90. Taiwan Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 91. Taiwan Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 92. Australia Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 93. Australia Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 94. Rest of Asia-Pacific Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 95. Rest of Asia-Pacific Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 96. Europe Weight Loss Drugs Sales, by Country Units (2015-2020)
  • Table 97. Europe Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 98. Europe Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 99. Germany Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 100. Germany Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 101. France Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 102. France Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 103. Italy Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 104. Italy Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 105. United Kingdom Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 106. United Kingdom Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 107. Netherlands Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 108. Netherlands Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 109. Rest of Europe Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 110. Rest of Europe Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 111. MEA Weight Loss Drugs Sales, by Country Units (2015-2020)
  • Table 112. MEA Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 113. MEA Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 114. Middle East Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 115. Middle East Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 116. Africa Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 117. Africa Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 118. North America Weight Loss Drugs Sales, by Country Units (2015-2020)
  • Table 119. North America Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 120. North America Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 121. United States Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 122. United States Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 123. Canada Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 124. Canada Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 125. Mexico Weight Loss Drugs Sales, by Type Units (2015-2020)
  • Table 126. Mexico Weight Loss Drugs Sales, by Application Units (2015-2020)
  • Table 127. Weight Loss Drugs: by Type(USD/Units)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Weight Loss Drugs: by Type(USD Million)
  • Table 138. Weight Loss Drugs Liquid , by Region USD Million (2021-2026)
  • Table 139. Weight Loss Drugs Tablets , by Region USD Million (2021-2026)
  • Table 140. Weight Loss Drugs: by Application(USD Million)
  • Table 141. Weight Loss Drugs Weight-reducing Aid , by Region USD Million (2021-2026)
  • Table 142. Weight Loss Drugs Other , by Region USD Million (2021-2026)
  • Table 143. South America Weight Loss Drugs, by Country USD Million (2021-2026)
  • Table 144. South America Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 145. South America Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 146. Brazil Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 147. Brazil Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 148. Argentina Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 149. Argentina Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 150. Rest of South America Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 151. Rest of South America Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 152. Asia Pacific Weight Loss Drugs, by Country USD Million (2021-2026)
  • Table 153. Asia Pacific Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 154. Asia Pacific Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 155. China Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 156. China Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 157. Japan Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 158. Japan Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 159. India Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 160. India Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 161. South Korea Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 162. South Korea Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 163. Taiwan Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 164. Taiwan Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 165. Australia Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 166. Australia Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 167. Rest of Asia-Pacific Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 168. Rest of Asia-Pacific Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 169. Europe Weight Loss Drugs, by Country USD Million (2021-2026)
  • Table 170. Europe Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 171. Europe Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 172. Germany Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 173. Germany Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 174. France Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 175. France Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 176. Italy Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 177. Italy Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 178. United Kingdom Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 179. United Kingdom Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 180. Netherlands Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 181. Netherlands Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 182. Rest of Europe Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 183. Rest of Europe Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 184. MEA Weight Loss Drugs, by Country USD Million (2021-2026)
  • Table 185. MEA Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 186. MEA Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 187. Middle East Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 188. Middle East Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 189. Africa Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 190. Africa Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 191. North America Weight Loss Drugs, by Country USD Million (2021-2026)
  • Table 192. North America Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 193. North America Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 194. United States Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 195. United States Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 196. Canada Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 197. Canada Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 198. Mexico Weight Loss Drugs, by Type USD Million (2021-2026)
  • Table 199. Mexico Weight Loss Drugs, by Application USD Million (2021-2026)
  • Table 200. Weight Loss Drugs Sales: by Type(Units)
  • Table 201. Weight Loss Drugs Sales Liquid , by Region Units (2021-2026)
  • Table 202. Weight Loss Drugs Sales Tablets , by Region Units (2021-2026)
  • Table 203. Weight Loss Drugs Sales: by Application(Units)
  • Table 204. Weight Loss Drugs Sales Weight-reducing Aid , by Region Units (2021-2026)
  • Table 205. Weight Loss Drugs Sales Other , by Region Units (2021-2026)
  • Table 206. South America Weight Loss Drugs Sales, by Country Units (2021-2026)
  • Table 207. South America Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 208. South America Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 209. Brazil Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 210. Brazil Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 211. Argentina Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 212. Argentina Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 213. Rest of South America Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 214. Rest of South America Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 215. Asia Pacific Weight Loss Drugs Sales, by Country Units (2021-2026)
  • Table 216. Asia Pacific Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 217. Asia Pacific Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 218. China Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 219. China Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 220. Japan Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 221. Japan Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 222. India Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 223. India Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 224. South Korea Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 225. South Korea Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 226. Taiwan Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 227. Taiwan Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 228. Australia Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 229. Australia Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 230. Rest of Asia-Pacific Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 231. Rest of Asia-Pacific Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 232. Europe Weight Loss Drugs Sales, by Country Units (2021-2026)
  • Table 233. Europe Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 234. Europe Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 235. Germany Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 236. Germany Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 237. France Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 238. France Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 239. Italy Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 240. Italy Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 241. United Kingdom Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 242. United Kingdom Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 243. Netherlands Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 244. Netherlands Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 245. Rest of Europe Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 246. Rest of Europe Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 247. MEA Weight Loss Drugs Sales, by Country Units (2021-2026)
  • Table 248. MEA Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 249. MEA Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 250. Middle East Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 251. Middle East Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 252. Africa Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 253. Africa Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 254. North America Weight Loss Drugs Sales, by Country Units (2021-2026)
  • Table 255. North America Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 256. North America Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 257. United States Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 258. United States Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 259. Canada Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 260. Canada Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 261. Mexico Weight Loss Drugs Sales, by Type Units (2021-2026)
  • Table 262. Mexico Weight Loss Drugs Sales, by Application Units (2021-2026)
  • Table 263. Weight Loss Drugs: by Type(USD/Units)
  • Table 264. Research Programs/Design for This Report
  • Table 265. Key Data Information from Secondary Sources
  • Table 266. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Weight Loss Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Weight Loss Drugs: by Application USD Million (2015-2020)
  • Figure 6. South America Weight Loss Drugs Share (%), by Country
  • Figure 7. Asia Pacific Weight Loss Drugs Share (%), by Country
  • Figure 8. Europe Weight Loss Drugs Share (%), by Country
  • Figure 9. MEA Weight Loss Drugs Share (%), by Country
  • Figure 10. North America Weight Loss Drugs Share (%), by Country
  • Figure 11. Global Weight Loss Drugs: by Type Units (2015-2020)
  • Figure 12. Global Weight Loss Drugs: by Application Units (2015-2020)
  • Figure 13. South America Weight Loss Drugs Share (%), by Country
  • Figure 14. Asia Pacific Weight Loss Drugs Share (%), by Country
  • Figure 15. Europe Weight Loss Drugs Share (%), by Country
  • Figure 16. MEA Weight Loss Drugs Share (%), by Country
  • Figure 17. North America Weight Loss Drugs Share (%), by Country
  • Figure 18. Global Weight Loss Drugs: by Type USD/Units (2015-2020)
  • Figure 19. Global Weight Loss Drugs share by Players 2020 (%)
  • Figure 20. Global Weight Loss Drugs share by Players (Top 3) 2020(%)
  • Figure 21. Global Weight Loss Drugs share by Players (Top 5) 2020(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 25. Amylin Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Amylin Pharmaceuticals, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. AstraZeneca Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. AstraZeneca Plc (United Kingdom) Revenue: by Geography 2020
  • Figure 29. F.Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. F.Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 31. GlaxoSmithKline Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. GlaxoSmithKline Plc (United Kingdom) Revenue: by Geography 2020
  • Figure 33. VIVUS, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. VIVUS, Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Lunan Pharmaceutical Group Corporation (China) Revenue, Net Income and Gross profit
  • Figure 36. Lunan Pharmaceutical Group Corporation (China) Revenue: by Geography 2020
  • Figure 37. Teva (Iseral) Revenue, Net Income and Gross profit
  • Figure 38. Teva (Iseral) Revenue: by Geography 2020
  • Figure 39. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 40. Novartis (Switzerland) Revenue: by Geography 2020
  • Figure 41. Global Weight Loss Drugs: by Type USD Million (2021-2026)
  • Figure 42. Global Weight Loss Drugs: by Application USD Million (2021-2026)
  • Figure 43. South America Weight Loss Drugs Share (%), by Country
  • Figure 44. Asia Pacific Weight Loss Drugs Share (%), by Country
  • Figure 45. Europe Weight Loss Drugs Share (%), by Country
  • Figure 46. MEA Weight Loss Drugs Share (%), by Country
  • Figure 47. North America Weight Loss Drugs Share (%), by Country
  • Figure 48. Global Weight Loss Drugs: by Type Units (2021-2026)
  • Figure 49. Global Weight Loss Drugs: by Application Units (2021-2026)
  • Figure 50. South America Weight Loss Drugs Share (%), by Country
  • Figure 51. Asia Pacific Weight Loss Drugs Share (%), by Country
  • Figure 52. Europe Weight Loss Drugs Share (%), by Country
  • Figure 53. MEA Weight Loss Drugs Share (%), by Country
  • Figure 54. North America Weight Loss Drugs Share (%), by Country
  • Figure 55. Global Weight Loss Drugs: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Amylin Pharmaceuticals, Inc. (United States)
  • AstraZeneca Plc (United Kingdom)
  • F.Hoffmann-La Roche Ltd. (Switzerland)
  • GlaxoSmithKline Plc (United Kingdom)
  • VIVUS, Inc. (United States)
  • Lunan Pharmaceutical Group Corporation (China)
  • Teva (Iseral)
  • Novartis (Switzerland)
Additional players considered in the study are as follows:
Taj Pharmaceuticals Ltd (India) , Kabir Life Sciences & Research (India) , Dm Pharma (United States) , China Zhongshan Pharm (China)
Select User Access Type

Key Highlights of Report


Sep 2021 247 Pages 68 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Weight Loss Drugs Market Quantitative research analysis
Global Weight Loss Drugs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Weight Loss Drugs Market are Abbott Laboratories (United States), Amylin Pharmaceuticals, Inc. (United States), AstraZeneca Plc (United Kingdom), F.Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline Plc (United Kingdom), VIVUS, Inc. (United States), Lunan Pharmaceutical Group Corporation (China), Teva (Iseral) and Novartis (Switzerland) etc.
Global Weight Loss Drug consumption is expected to grow in the forecasted period owing to a rise in awareness among people about their health and wellbeing. Weight loss drugs refer to a pharmacological agent used to reduce or control weight. The prominent drivers include consumer’s increased weight and increase in disposable income. According to the report in 2018 around 30% of People in the world are Obese or Overweight.

Know More About Global Weight Loss Drugs Market Report?

Have a Query? Click Here

Other Related Reports

Aspergillosis Drugs Comprehensive Study by Type (Allergic Bronchopulmonary Aspergillosis, Allergic Aspergillus Sinusitis, Invasive Aspergillosis, Cutaneous (skin) Aspergillosis, Chronic Pulmonary Asp...
$ 3750
Hydrocodone Bitartrate Comprehensive Study by Type (< 98%, > 98%), Application (Hydrocodone Bitartrate Capsule, Hydrocodone Bitartrate Extended-Release Tablets, Hydrocodone Bitartrate Oral Solutions)...
$ 3650
Ankle Splints Comprehensive Study by Type (Air-Stirrup Ankle Brace, Other), Application (High Ankle Sprains, Sub-acute Ankle Sprains, Chronic Ankle Sprains), Distribution Channel (Orthopedic Clinics,...
$ 3650
Omega 3 Comprehensive Study by Type (ALA (Alpha-Linolenic Acid), DHA (Docosahexaenoic Acid), EPA (Eicosapentaenoic Acid)), Application (Dietary Supplement, Pharmaceutical, Infant Formula, Food & Beve...
$ 3750
Ginseng Supplements Comprehensive Study by Type (Tablets, Capsules), Application (Children, Teenagers, Middle-aged, Senior), Distribution Channels (Pharmacy, Specil Restail, Supermarket, Other) Playe...
$ 3500
Dupuytren Contracture Drug Comprehensive Study by Type (Bupivacaine ER, MWPC-003, Others), Application (Clinic, Hospital, Others), Dupuytren Contracture (Type 1, Type2, Type 3), Diagnosis (Physical E...
$ 3350